1012-2966

1012-2966

S1012-29662024000100072

10.47993/gmb.v47i1.606

Brasil

00 00 2024

00 00 2024

47 1 72 85

1

1999 353 9152 9152

571-80

2

2022 63 3 3

3

2022 19 1 1

29

4

2018 69 4 4

249-5

5

2018 21 2 2

96-100

6

2008 11 1 1

32-43

7

Study of Women's Health Across the Nation

2015 175 4 4

531-9

8

2014 21 9 9

924-32

9

2016 23 10 10

1067-74

10

2010 13 6 6

534-43

11

2008 118 12 12

1234-40

12

2011 18 4 4

352-8

13

2011 26 4 4

840-9

14

2022 11 1 1

66-79

15

2019 394 10204 10204

1116-8

16

2002 288 3 3

321-33

17

2022 328 17 17

1747-65

18

2021 12

564781

19

2020 382 5 5

446-55

20

2020 20 1 1

71-85

21

“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel

2022 29 7 7

767-94

22

2015 100 11 11

3975-4011

23

ACOG Practice Bulletin No. 141

2014 123 1 1

202-16

24

1990 40 4 4

561-82

25

2009 2

193-202

26

2019 102 1 1

3-11

27

2010 10

11

28

2012 21 2 2

161-9

29

2009 12 ^s1 ^s1 1

86-90

30

2010 19 1 1

47-55

31

Cochrane Bias Methods Group Cochrane Statistical Methods Group

2011 343

d5928

32

2013

33

Ministerio de Salud y Protección Social

34

2014 161 4 4

249-60

35

2018 25 2 2

145-53

36

1996 88 4 4

587-92

37

1997 27 3 3

285-92

38

1999 2 1 1

29-36

39

2000 182 1 1

7-12

40

2004 291 13 13

1610-20

41

1994 20 2-3 2-3

209-13

42

1998 28 3 3

243-9

43

2002 115 12 12

1790-5

44

2020 31 12 12

2271-86

45

2019 104 5 5

1595-622

46

1993 168 3 3

824-30

47

2013 20 10 10

1098-105

48

2020 27 10 10

1126-36

49

2015 126 4 4

859-76

50

2019 184

1-7

51

2006 8 5 5

538-54

52

2017 16 8 8

941-54

53

2013 310 13 13

1353-68

54

2017 318 10 10

927-38

55

2015 3 3

CD002229

56

2000 904

502-6

57

2015 44 3 3

663-76

58

2017 92 10 10

1552-8

59

2017 38 3 3

173-88

60

2014 30 7 7

350-61

61

Heart and Estrogen/progestin Replacement Study

2003 138 1 1

1-9

62

2006 89 ^s4 ^s4 4

S37-41

63

1996 41 6 6

509-15

64

1999 32 1 1

41-50

65

2002 40 5 5

446-51

66

1963 185 2 2

131-2

67

2010 17 6 6

1122-7

68

2010 340

c2519

69

2007 115 7 7

840-5

70

2017 84

60-8

71

2010 304 15 15

1684-92

72

2017 109 9 9

djx001

73

2015 1 3 3

296-305

74

2015 10 9 9

75

2003 46 1 1

1-6

76

2016 91

25-35

77

Collaborative Group On Epidemiological Studies Of Ovarian Cancer

2015 385 9980 9980

1835-42

78

2009 302 3 3

298-305

79

2016 11 1 1

80

2008 111 6 6

1343-51

81

ESTRASORB Study Group

2006 13 2 2

222-31

82

2020 26 4 4

210-9

83

2004 2004 4 4

CD002978

84

2015 81 1 1

88-92

85

2006 26 7 7

1660-6

86

2014 69 2 2

75-82

87

2020 10 1 1

20631

88

2004 291 14 14

1701-12

89

2014 20 3 3

111-7

90

2022 29 4 4

483-90

91

2001 85 4 4

619-25

92

2005 8 ^s1 ^s1 1

3-63

93

2018 68 675 675

499-500

94

2019 364

k4810

95

2018 21 4 4

341-5

96

2022

97

2022 163

62-81

98

2021 12

564781

99

2020 26 1 1

63-78

100

HABITS Study Group

2008 100 7 7

475-82

101

2016 23 3 3

335-42

102

2017 146 2 2

427-35

103

2018 37 1 1

104

2013 16 ^s1 ^s1 1

44-53

105

2012 15 ^s1 ^s1 1

3-10

106

2021 62 4 4

1-13